Xconomy National

Archives

by in

Entry	Author	Date	Location
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News	Luke Timmerman	01/20/11	Seattle
Cell Therapeutics Snags $25M	Luke Timmerman	01/13/11	Seattle
Cell Therapeutics Seeks EU Approval	Luke Timmerman	11/01/10	Seattle
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News	Luke Timmerman	10/21/10	Seattle
Cell Therapeutics Adds $21M	Luke Timmerman	10/20/10	Seattle
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News	Luke Timmerman	09/23/10	Seattle
Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares	Luke Timmerman	09/16/10	Seattle
Biotech Drug Discovery in Seattle: A Look Back	Stewart Lyman	06/11/10	Seattle
Seattle Genetics Grows Up Fast, Valocor Seeks to Fight Acne, Cell Therapeutics Nabs $21M & More Seattle-Area Life Sciences News	Luke Timmerman	05/27/10	Seattle
Cell Therapeutics Adds $21M	Luke Timmerman	05/24/10	Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News	Luke Timmerman	04/22/10	Seattle
Cell Therapeutics Cuts 36 Employees	Luke Timmerman	04/15/10	Seattle
Dendreon’s Pricing Question, UW’s $300M Stimulus Windfall, Cell Therapeutics Rejected by FDA, & More Seattle-Area Life Sciences News	Luke Timmerman	04/15/10	Seattle
Cell Therapeutics Shareholder Meeting Postponed, After FDA Rejection	Luke Timmerman	04/09/10	Seattle
Cell Therapeutics Lymphoma Drug Fails to Win FDA Approval	Luke Timmerman	04/09/10	Seattle
Our Top 20 Stories of the First Quarter: Amazon, Cell Therapeutics, Dendreon, Microsoft, and More	Gregory T. Huang	04/02/10	Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News	Luke Timmerman	03/25/10	Seattle
Cell Therapeutics Looks to Pick up the Pieces After FDA Smacks Down Lymphoma Drug	Luke Timmerman	03/23/10	Seattle
Cell Therapeutics Shares Crash as Lymphoma Drug Gets Shot Down by FDA Panel	Luke Timmerman	03/22/10	Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug	Luke Timmerman	03/22/10	Seattle
Cell Therapeutics FDA Panel Primer: Take Two	Luke Timmerman	03/19/10	Seattle
Cell Therapeutics Passes Factory Test	Luke Timmerman	03/08/10	Seattle
Cell Therapeutics Offers Execs Big Cash Bonuses As Stock Trades Below a Buck	Luke Timmerman	03/05/10	Seattle
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It	Stewart Lyman	03/05/10	Seattle
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News	Luke Timmerman	03/04/10	Seattle
Cell Therapeutics Gets New Day in Front of FDA	Luke Timmerman	03/01/10	Seattle
Cell Therapeutics Panel Stalled, Medical Device Angels Band Together, Calypso Cuts Side Effects, & More Seattle-Area Life Sciences News	Luke Timmerman	02/18/10	Seattle
Cell Therapeutics Shares Fall as FDA Says Lymphoma Drug Has “Substantial” Side Effects	Luke Timmerman	02/08/10	Seattle
Page 1 of 4	next page »